AURX — Nuo Therapeutics Inc · rev $3.1M

Nuo Therapeutics Inc (AURX) is a biotechnology company listed on US.

Latest reported AURX revenue for 2026-06-30 was $3.1M. Net income was -$896.1K. AURX currently screens at market cap $72.1M.

Use this AURX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AURX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AURX SEC filings page. Lician reads the product cache first so this HTML stays unique to Nuo Therapeutics Inc even when a live quote feed is slow.

Nuo Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full AURX income, balance, and cash tables.

  • Revenue$3.3M
  • Net Income-$2.5M
  • Total Assets$1.8M
  • Total Debt$0
  • Free Cash Flow-$1.1M

AURX recent filings